The wtf (With Tail Fragments) gene family in Schizosaccharomyces pombe encodes multi-transmembrane proteins that function as toxin-antidote systems. These genes produce proteins with identical transmembrane domains but differ in their N-terminal cytosolic tails. The antidote variant (e.g., Cw9a) contains PY motifs that recruit Rsp5/NEDD4 family ubiquitin ligases, leading to ubiquitination and endosomal degradation. This mechanism prevents toxicity by neutralizing the toxin (e.g., Cw9t) . While "wtf25" is not explicitly mentioned, the study highlights conserved ubiquitination pathways that could inform antibody-mediated therapies targeting similar systems.
Antibodies consist of two Fabs (fragment antigen-binding domains) and an Fc (fragment crystallizable domain), linked by a flexible hinge region. The Fabs bind antigens via variable domains (VH and VL), while the Fc interacts with immune receptors to mediate effector functions like ADCC (antibody-dependent cellular cytotoxicity) . Recombinant antibodies, such as single-chain variable fragments (scFvs), are engineered for therapeutic applications, including targeting viral entry points (e.g., HSV) or tumor-associated antigens .
The anti-CD25 antibodies BA9 and BT942 exemplify strategies for modulating immune responses. These antibodies selectively deplete regulatory T cells (Tregs) in the tumor microenvironment while sparing activated effector T cells. Their efficacy is mediated through ADCC, with IC50 values of 0.025–0.096 μg/mL against CD25-expressing targets . A hypothetical "wtf25 Antibody" could leverage similar mechanisms if engineered to target a specific antigen involved in toxicity or immune regulation.
Next-generation bnAbs, such as BD55-1205 against SARS-CoV-2, demonstrate how structural engineering can achieve broad reactivity. BD55-1205 binds the receptor-binding motif (RBM) of the viral spike protein via extensive polar interactions, enabling neutralization of diverse variants . A "wtf25 Antibody" designed for broad specificity could apply analogous strategies to counter evolving targets.
KEGG: spo:SPCC1919.06c
STRING: 4896.SPCC1919.06c.1